Altered NOTCH pathway signaling in DLBCL and other lymphomas is associated with shorter PFS and OS.[5] Mutated CIITA causes loss of MHC class II expression leading to immune escape and treatment resistance. This evidence concerns the gene CIITA and diffuse large B-cell lymphoma.